Negative Pressure Wound Therapy (NPWT) Market

The global Negative Pressure Wound Therapy (NPWT) Market is valued at USD 2.7 Billion in 2023 and is projected to reach a value of USD 4.77 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 6.5% between 2024 and 2032. The market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune conditions.

Key Highlights

• Based on the Product, the Conventional NPWT Devices category accounted for significant market share of 83.1% in 2023
• In 2023, by End-use, Hospital dominated the market with significant market share of 43.5%
• North America dominated the market with 45.1% market share in 2023
• Single-use NPWT devices are becoming increasingly popular in wound care management compared to traditional options. For instance, in January 2022, Smith+Nephew announced that the FDA granted clearance for its Single Use Negative Pressure Wound Therapy (sNPWT) Systems, PICO 7 and PICO 14, for new applications in closed surgical incisions.

Product Overview

​The Product segment is divided into Conventional NPWT Devices, Single-use NPWT Devices, NPWT Accessories. The Conventional NPWT Devices segment held the dominant share in 2023, accounting for significant market share of 83.1%.

Conventional NPWT Devices segment dominated the market due to the high cost of conventional NPWT devices and their growing global adoption. These devices help shorten hospital stays, reducing overall treatment costs and making them more appealing than single-use alternatives. Moreover, conventional NPWT devices can be rented or purchased, which increases their usage in developing countries with lower purchasing power, thereby driving the segment's growth.

The single-use NPWT devices segment is expected to experience the fastest growth during the forecast period due to their broad application in home care settings. According to the National Center for Biotechnology Information (NCBI), the estimated cost per patient for single-use NPWT was USD 19,986, compared to USD 20,572 for surgical complications (SC).

End-use Overview

The End use segment is divided into Hospital, Specialty Clinics, Home Healthcare, Others. In 2023, the Hospital segment held largest share of 43.5% in the Negative Pressure Wound Therapy (NPWT) market.

Hospitals segment led the market due to a high patient volume resulting from the increasing prevalence of chronic diseases worldwide. NPWT devices are extensively utilized in various hospital environments, including acute care centers and community hospitals. Furthermore, the anticipated growth in the number of hospitals is expected to drive this segment. According to the American Hospital Association, approximately 6,129 hospitals were operational in the U.S. in 2023. The establishment of new healthcare facilities and the influx of patients requiring wound treatment are expected to boost the demand for negative pressure wound therapy devices during the forecast period.

Home healthcare segment is projected to experience the fastest growth in the coming years. NPWT therapies designed for home use are gaining traction due to the development of advanced single-use and traditional NPWT systems. These innovations reduce the need for hospitalization, making the overall treatment more cost-effective when delivered in a home environment.

Regional Overview

In 2023, the North America captured 45.1% of the revenue share.

North America Negative Pressure Wound Therapy (NPWT) market is driven by the increasing number of road accidents, sports-related injuries, and the presence of numerous key industry players in the region. The development of advanced and cost-effective medical devices continues to strengthen the region’s market dominance. Furthermore, the expanding number of hospitals and the aging population are key contributors to the region's market growth.

U.S. {Keyword}} market, valued at USD 772.2 Million in 2023 to USD 1317.01 Million in 2032, is anticipated to grow at a CAGR of 6.1% from 2024 to 2032. The U.S. market is driven by the high prevalence of chronic wounds in the U.S., along with the increasing elderly population, which is expected to drive expansion. For instance, in May 2023, the CDC reported that 6 out of 10 adults in the U.S. are living with a chronic condition, such as cancer, heart disease, or diabetes.

Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period, driven by the expanding target population with rising rates of chronic diseases, increasing demand for medical equipment, and supportive government policies. Additionally, the booming medical tourism industry and improvements in healthcare infrastructure are expected to drive the demand for NPWT in the region.

China holds the largest market share within the Asia Pacific market. According to a report by the National Library of Medicine, China's aging population is growing, leading to a higher prevalence of diabetes and diabetic foot conditions. These factors are anticipated to fuel the segment's growth throughout the forecast period.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Technological Advancements: Ongoing innovations in NPWT devices, such as portable, single-use systems and integrated dressing solutions, are enhancing the efficiency, convenience, and patient outcomes.
• Increased Focus on Home Care: With the rise of home healthcare services, there is a growing demand for portable and user-friendly NPWT devices that allow patients to continue treatment outside of clinical settings, reducing hospital stays and overall healthcare costs
• Expansion of Indications: NPWT systems are being cleared for a wider range of applications, including surgical incisions, diabetic foot ulcers, and chronic wounds, expanding the market potential and addressing the growing burden of wound-related complications in various patient populations
• Growing Adoption of Single-Use Systems: The increasing preference for disposable NPWT systems, such as Smith+Nephew’s PICO, is driven by their convenience, reduced risk of cross-contamination, and cost-effectiveness compared to traditional multi-use devices

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Growing prevalence of chronic diseases drives the market

The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular conditions, is a significant driver of the Negative Pressure Wound Therapy (NPWT) market. For instance, according to a report from the World Health Organization (WHO) in March 2023, approximately 422 million people worldwide are living with diabetes. This disorder may increase the frequency and severity of various types of wounds, such as infections, ulcerations (like ulcers on the legs and foot), and acute wounds after trauma or surgery. Advanced therapeutic methods are needed for wounds that do not heal, such as non-healing ulcers and infections, which are frequently caused by chronic diseases. The need for efficient wound care treatments, such as NPWT devices, has increased due to the aging of the global population and the rise in the occurrence of chronic illnesses.

High cost of NPWT devices poses a significant restraint to market growth

Hospitals, clinics, and smaller healthcare facilities may find it difficult to purchase NPWT equipment because of their high initial costs, especially in developing nations with limited budgets. Adoption may be further hampered by the continuous maintenance, training, and operational expenses related to NPWT systems. Consequently, many healthcare providers may opt for less expensive, traditional wound care methods, leading to lower market penetration of NPWT devices. Furthermore, the limited adoption of non-painful well-being therapy (NPWT) among healthcare professionals may be attributed to a lack of knowledge and comprehension of its benefits, which could limit the market's potential growth.

Competitive Landscape

The Negative Pressure Wound Therapy (NPWT) market is characterized by the presence of several key players, including Smith+Nephew, Convatec Group PLC, Medela, Mölnlycke Health Care, and 3M, among others. These companies are focusing on product innovations, strategic acquisitions, and technological advancements to enhance their market positions. Recent developments, such as Smith+Nephew's innovative technology contract for its PICO Single Use NPWT Systems and Convatec's acquisition of 30 Technology Limited’s anti-infective nitric oxide platform, reflect a trend toward expanding product portfolios and strengthening R&D capabilities. Additionally, FDA clearances for new applications and the introduction of novel wound care solutions, such as Medela's Invia Integrated Dressing, are driving competition as firms strive to address the growing demand for advanced wound care solutions.

The key players in the global Negative Pressure Wound Therapy (NPWT) market include - 3M, Talley Group Ltd (Direct Healthcare Group), Smith+Nephew, Mölnlycke Health Care, Medela AG, DeRoyal Industries, Inc., Convatec Inc., Cardinal Health, Paul Hartmann AG among others.

Recent Market Developments

Smith+Nephew Secures Innovative Technology Contract for PICO NPWT Systems from Vizient

• In May 2023, Vizient, Inc. awarded Smith+Nephew an innovative technology contract for its PICO Single Use Negative Pressure Wound Therapy Systems. This contract aims to boost research and development in NPWT, thereby fostering market growth

Convatec Acquires Anti-Infective Nitric Oxide Technology Platform from 30 Technology

• In April 2023, Convatec Group PLC acquired the anti-infective nitric oxide technology platform from 30 Technology Limited, which includes new product assets and R&D. Along with improving wound care, Convatec intends to apply this technology across other business areas

Medela Launches New Invia Integrated Dressing for Wound Care

• In August 2023, Medela introduced the new Invia Integrated Dressing, designed for various wound types

FDA Clears Smith+Nephew's PICO sNPWT Systems for Expanded Surgical Indications

• In January 2022, Smith+Nephew announced FDA clearance for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems for expanded use in closed surgical incisions, helping reduce the risk of dehiscence, postoperative seroma, and both superficial and deep incisional Surgical Site Infections (SSIs)

The global Negative Pressure Wound Therapy (NPWT) market can be categorized as Product, Wound Type,

End-use and Region.